总部位于多伦多的MolecuLight筹集了1170万美元的C轮融资,用于全球扩张和改善伤口护理. Toronto-based MolecuLight raises $11.7M in Series C financing for global expansion and improved wound care.

多伦多的MolecuLight, 一位荧光成像领头人,与现有投资者一道,在EDC、Prosegur和Azahar领导的系列C中筹集了11.7M美元的资金。 Toronto-based MolecuLight, a fluorescence imaging leader, raised $11.7M in Series C financing led by EDC, Prosegur, and Azahar, with existing investors. 基金将扩大美国、加拿大和欧盟的全球覆盖面,使各种护理环境受益。 Funds will expand global reach in US, Canada, and EU, benefiting various care settings. MolecuLight的装置使伤口的细菌实时可视化,导致更好的检测、量化、治疗和伤口愈合结果。 MolecuLight's devices enable real-time bacteria visualization in wounds, leading to better detection, quantification, treatment, and wound healing outcomes.